Oxoiron(IV) in chloroperoxidase compound II is basic: Implications for P450 chemistry

Science

Volumn 304, Issue 5677, 2004, Pages 1653-1656

  Green, Michael T ^a   Dawson, John H ^b   Gray, Harry B ^c  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISSOCIATION; HYDROCARBONS; INORGANIC ACIDS; POLYPEPTIDES; REDUCTION; X RAY SPECTROSCOPY;

DISSOCIATION CONSTANT; OXYGENEATION CYCLE;

ENZYMES;

CHLORIDE PEROXIDASE; CYTOCHROME C OXIDASE; CYTOCHROME P450; HORSERADISH PEROXIDASE; HYDROCARBON; IRON; IRON DERIVATIVE; LIGAND; NITROGEN; OXOIRON; OXYGEN; POLYPEPTIDE; RADICAL; SULFUR; UNCLASSIFIED DRUG;

ABSORPTION SPECTROSCOPY; ARTICLE; CALIBRATION; CHEMICAL REACTION; ENZYME ACTIVITY; ENZYME SUBSTRATE; EXTENDED X RAY ABSORPTION FINE STRUCTURE; MEASUREMENT; PRIORITY JOURNAL; ROENTGEN SPECTROSCOPY; TEMPERATURE;

CHEMISTRY, PHYSICAL; CHLORIDE PEROXIDASE; CYTOCHROME P-450 ENZYME SYSTEM; ELECTRONS; FOURIER ANALYSIS; FREE RADICALS; HORSERADISH PEROXIDASE; HYDROCARBONS; HYDROGEN-ION CONCENTRATION; HYDROXYLATION; IRON; KINETICS; LIGANDS; ORGANOMETALLIC COMPOUNDS; OXIDATION-REDUCTION; OXYGEN; PROTONS; SPECTRUM ANALYSIS;

ARMORACIA RUSTICANA;

EID: 2942679678     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1096897     Document Type: Article

References (41)

1. P. J. Daborn et al., Science 297, 2253 (2002).
2. R. J. Nelson et al., Nature 378, 383 (1995).
3. P. L. Huang et al., Nature 377, 239 (1995).
4. B. Fisslthater et al., Nature 401,493 (1999).
5. X.-Q. Wei et al., Nature 375, 408 (1995).
6. J. T. Groves, Proc. Natl. Acad. Sci. U.S.A. 100, 3569 (2003).
7. M. M. Palcic, R. Rutter, T. Araiso, L P. Hager, H. B. Dunford, Biochem. Biophys. Res. Commun. 94, 1123 (1980).
8. T. Egawa et al., J. Biol. Inorg. Chem. 6, 46 (2001).
9. R. Rutter et al., Biochemistry 23, 6809 (1984).
10. Hoffman and co-workers have observed a number of intermediates before P450-I formation but no spectroscopic evidence for the buitdup of compound I (11).
11. B. M. Hoffman, Proc. Natl. Acad. Sci. U.S.A. 100, 3575 (2003).
12. M. T. Green, J. Am. Chem. Soc. 121, 7939 (1999).
13. J. Antony, M. Grodzicki, A. X. Trautwein, J. Phys. Chem. A 101, 2692 (1997).
14. J. C. Schöneboom et al.,J. Am. Chem. Soc. 124, 8142 (2002).
15. -1) antiferromagnetic coupling between its S = 1 iron(IV)-oxo unit and S = 1/2 radical. Calculations On ferryl radicals indicate that axialtigand spin density favors antiferromagnetic coupling in these intermediates (16).
16. M. T. Green, J. Am. Chem. Soc. 123, 9218 (2001).
17. With the use of Gaussian 98, we performed density functional calculations (B3LYP/6-311G) on a ferryl porphine with a methyl thiotate ligand and the appropriate distal ligand.
18. cam was expressed in Escherichia coli and purified by standard procedures. The camphor-bound (HS) sample was ≈ 4 mM In P450 (Rz = 1.56). The substrate-free (LS) sample was ≈ 2mM (Rz = 1.35). Both samples were in potassium phosphate buffer (40 mM and pH = 7.5). The HS sample also contained 100 mM KCI and 10 mM camphor. Horseradish peroxidase (Sigma) was purified according to standard methods. HRP (Rz - 3.2) and stock solutions of peracetic acid and ascorbate were used to generate HRP-II and HRP-I according to known procedures. XAS samples (≈ 2 mM in 0.3 M potassium phosphate) were at pH = 6.
19. A. L. Ankudinov, B. Ravel, J. J. Rehr. S. D. Conradson. Phys. Rev. B 58, 7565 (1998).
20. J. E. Penner-Hahn et al., J. Am. Chem. Soc. 108, 7819 (1986).
21. T. Walter et al., J. Inorg. Biochem. 78, 117 (2000).
22. With the use of a stopped flow apparatus, we examined the visible absorption spectrum of CPO-II under steady state conditions (using peracetic acid and ascorbate) at pH values of 3.5 and 6.9. No difference in the absorption maxima of the Soret (437 nm) or Q bands (541 and 571 nm) of CPO-II was observed. Minor variations in the bluest peak (372 nm) are attributable to changes in the relative steady state concentrations of compounds I and II as a function of pH (23). CPO-I absorbs at 367 and 688 nm. CPO undergoes an irreversible alkaline transition above pH = 7.
23. A. M. Lambeir, H. B. Dunford, M. A. Pickard, Eur. J. Biochem. 163, 123 (1987).
24. M. Chance, L Powers, T. Poulos, B. Chance, Biochemistry 25, 1266 (1986).
25. A. J. Sitter, C. M. Reczek. J. Terner, J. Biol. Chem. 260, 7515 (1985).
26. C. M. Reczek, A. J. Sitter, J. Temer Mol. Struct. 214, 27 (1989).
27. J. R. Kincaid, Y. Zheng, J. Al-Mustafa, K. Czarnecki, J. Biol. Chem. 271, 28805 (1996).
28. B. Chance et al., Arch. Biochem. Biophys. 235, 596 (1984).
29. Recent crystallographic investigations indicate that other protein ferryl species may be protonated as well. Reported Fe-O bond lengths in HRP-II, myoglobin-II (Mb-II), and cytochrome c peroxidase-I (CCP-I) are 1.8, 1.92, and 1.87 A, respectively (30-32). However, it is difficult to reconcile the observed ferryl stretching frequencies with the long Fe-O bonds found in these crystal structures. Much weaker stretches would be expected for these intermediates, if their Fe-O bonds were truly 8, 16, and 13% longer than that of HRP-I.
30. G. I. Berglund et al., Nature 417, 463 (2002).
31. H.-P. Hersleth, B. Dalhus, C. H. Görbitz, K. K. Andersson, Biol. Inorg. Chem. 7, 299 (2002).
32. C. A. Bonagura et al., Biochemistry 42, 5600 (2003).
33. F. van Rantwijk, R. A. Sheldon, Curr. Opin. Biotechnol. 11, 554 (2000).
34. H. B. Dunford, Heme Peroxidases (Wiley-VCH, New York, 1999).
35. M. P. J. van Deurzen, F. van Rantwijk, R. A. Sheldon, Tetrahedron 53, 13183 (1997).
36. J. M. Mayer, Acc. Chem. Res. 31, 441 (1998).
37. F. G. Bordwell, J.-P. Cheng, G.-Z. Ji, A. V. Satish, X. Zhang, J. Am. Chem. Soc. 113, 9790 (1991).
38. Y. Hayashi, I. Yamazaki, J. Biol. Chem. 254, 9101 (1979).
39. CPO-I oxidizes chloride at pH = 3 (40). It must have a two-electron reduction potential in excess of 1.18 V at pH = 6. The two-electron reduction potential of peroxide (1.41 V at pH. = 6) provides an upper limit for the CPO-I reduction potential.
40. R. D. Libby, J. A. Thomas, L. W. Kaiser, L. P. Hager, J. Biol. Chem. 257, 5030 (1982).
41. We thank M. Bollinger, I. Dmochowski, J. Labinger, M. Machczynski, M. McGuirl, A. Tezcan, and J. Winkler for helpful discussions: G. George, I. Pickering, M. Latimer, B. Butler, A. Soo Hoo, S. Debeer George, D. Durkin, and other SSRL staff members for assistance with XAS measurements; and L Hager for a CPO sample used in the initial experiments. Supported by NIH (GM26730 to J.H.D. and DK19038 to H.B.G.), NSF, and the Arnold and Mabel Beckman Foundation. 18 February 2004; accepted 21 April 2004